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Selective Removal of the Selenocysteine tRNA[Ser]Sec Gene (Trsp)
in Mouse Mammary Epithelium
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Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland
217014; and Laboratory of Molecular Genetics, School of Biological Sciences,
Seoul National University, Seoul 151-742, Korea5
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Mice homozygous for an allele encoding the selenocysteine (Sec) tRNA[Ser]Sec gene (Trsp) flanked by loxP
sites were generated. Cre recombinase-dependent removal of Trsp in these mice was lethal to embryos. To
investigate the role of Trsp in mouse mammary epithelium, we deleted this gene by using transgenic mice
carrying the Cre recombinase gene under control of the mouse mammary tumor virus (MMTV) long terminal
repeat or the whey acidic protein promoter. While both promoters target Cre gene expression to mammary
epithelium, MMTV-Cre is also expressed in spleen and skin. Sec tRNA[Ser]Sec amounts were reduced by more
than 70% in mammary tissue with either transgene, while in skin and spleen, levels were reduced only with
MMTV-Cre. The selenoprotein population was selectively affected with MMTV-Cre in breast and skin but not
in the control tissue, kidney. Moreover, within affected tissues, expression of specific selenoproteins was
regulated differently and often in a contrasting manner, with levels of Sep15 and the glutathione peroxidases
GPx1 and GPx4 being substantially reduced. Expression of the tumor suppressor genes BRCA1 and p53 was
also altered in a contrasting manner in MMTV-Cre mice, suggesting greater susceptibility to cancer and/or
increased cell apoptosis. Thus, the conditional Trsp knockout mouse allows tissue-specific manipulation of Sec
tRNA and selenoprotein expression, suggesting that this approach will provide a useful tool for studying the
role of selenoproteins in health.
Selenium is an essential micronutrient in the diet of mam-
mals and numerous other life forms (see reference 26 for a
review). Many health benefits have been attributed to this
element, including a role in the prevention of cancer (10) and
heart disease and other cardiovascular and muscle disorders
(11), in delaying the aging process (33) and the onset of AIDS
in human immunodeficiency virus-positive patients (1), in male
reproduction (17), in mammalian development (5), in immune
function (33), and as an antiviral agent (2). Selenium is incor-
porated into protein in the form of selenocysteine (Sec), and
Sec has its own tRNA (designated Sec tRNA[Ser]Sec) and its
own code word, UGA (26). Sec is indeed the 21st naturally
occurring amino acid in the genetic code. Most certainly, the
health benefits of selenium are due in large part to its presence
in protein (26).
Sec tRNA[Ser]Sec is the only known tRNA that governs the
expression of an entire class of proteins, the selenoproteins
(26). This provides a unique opportunity to study the expres-
sion of selenoproteins by manipulating the levels and char-
acteristics of Sec tRNA[Ser]Sec. For example, the levels of
numerous selenoproteins were reduced in a protein- and
tissue-specific manner in transgenic mice carrying mutant Sec
tRNA[Ser]Sec transgenes lacking the highly modified base iso-
pentenyladenosine in its anticodon (37). Glutathione peroxi-
dase 1 (GPx1) and thioredoxin reductases 1 (TR1) and 3
(TR3) were the most and least affected selenoproteins, respec-
tively, and selenoprotein expression was most and least af-
fected in liver and testes, respectively. Increasing the level of
Sec tRNA[Ser]Sec expression by severalfold (36, 37) or decreas-
ing the level of expression by as much as one-half (5, 7) had
no effect on selenoprotein expression. Removal of the Sec
tRNA[Ser]Sec gene (Trsp), however, is embryonic lethal (5).
One means of examining the role of genes that are embryonic
lethal is gene silencing on a conditional basis by using Cre/loxP
technology (see recent reviews in references 3 and 28). Fur-
thermore, this approach affords us an opportunity to study the
role of selenoproteins in specific tissues and organs as well as
their relevance to health.
We therefore generated a conditional knockout of Trsp by
inserting a fragment of mouse DNA encoding this gene into a
vector containing the neomycin (Neo) and thymidine kinase
(TK) genes. The newly prepared construct has three loxP sites
flanking Neo and Trsp. We generated a mouse that selectively
* Corresponding author. Mailing address: National Cancer Institute,
National Institutes of Health, Building 37, Room 2D09, Bethesda, MD
20892. Phone: (301) 496-2797. Fax: (301) 435-4957. E-mail: hatfield
@dc37a.nci.nih.gov.
† Present address: The Wistar Institute, Philadelphia, PA 19104.
‡ Present address: Department of Biochemistry, School of Dentistry,
The University of Tokoushima, Tokushima 770-8504, Japan.
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replaced the Trsp wild-type allele with the loxP-Neo-loxP-Trsp-
loxP construct. We also selectively removed Neo in recombi-
nant embryonic stem (ES) cells by transfection with a construct
encoding the Cre recombinase that generated a mouse encod-
ing floxed Trsp (designated Trspfl). The Trspfl/ mouse became
the parental line for studying conditional knockout of Trsp in
the Cre-loxP system.
Breast is an ideal tissue for studying the role of selenopro-
teins either in its development or in the formation of breast
cancer because several model systems that target the mammary
gland have been developed in mice (12, 29, 42, 43). Further-
more, this tissue is a major focus of cancer occurrence in
women. In inherited breast and ovarian cancer, the BRCA1
tumor suppressor gene frequently appears to be altered (34).
Germ line mutations in BRCA1 are associated with approxi-
mately two-thirds of all familial breast cancers (18). BRCA1
plays an essential role in several cellular pathways, including
transcriptional control, DNA repair, and transcription-coupled
repair of oxidative DNA damage (13, 41). p53 is another tumor
suppressor gene which normally plays a central role in main-
taining the genetic integrity of the cell by preventing cells with
damaged DNA from further proliferation. Mutation and de-
letion of p53 are the most common genetic defects seen in
clinical cancer (15). BRCA1 and p53 are known to physically
interact, with BRCA1 acting as a coactivator of p53 (45).
Transgenic mice carrying Cre recombinase under the control
of two different regulatory elements, the promoter for the
whey acidic protein gene (WAP) and that for the mouse mam-
mary tumor virus (MMTV) long terminal repeat, have shown
a high specificity for expression in mammary epithelium (42,
44). However, the two promoters have different temporal and
tissue specificities. WAP is expressed in alveolar cells in mid-
pregnancy and lactation, while MMTV is already expressed in
ductal epithelial cells of newborns and also in skin and spleen
(42, 43).
In the present study, we crossed Trspfl/fl mice with Trspfl/
WAP-Cre or MMTV-Cre mice to generate offspring carrying
two floxed alleles and Cre recombinase. The effect of the Cre
recombinase-driven promoters on the expression of Sec
tRNA[Ser]Sec and, consequently, on the expression of the sel-
enoprotein population are reported herein. These studies es-
tablish a new animal model to assess the role of selenoproteins
in health in a selenoprotein-specific and organ-specific man-
ner.
MATERIALS AND METHODS
Materials. The pPNT and the pLMJ58 plox/Neo vectors were from two of our
laboratories (those of B. J. Lee and L. Tessarollo, respectively), the pBS246
vector was from Gibco-BRL, and the pBSKS vector was from Stratagene. The
129/SV mouse genomic library was obtained from Incyte Genomics, [75Se]sele-
nious acid (specific activity, 1,000 Ci/mmol) was from the Research Reactor
Facility, University of Missouri, Columbia, Mo., and [3H]serine (specific activity,
36 Ci/mmol) was from Amersham. Restriction endonucleases and agarose were
obtained from New England Biolabs and/or Gibco-BRL. Vent DNA polymerase,
Taq DNA polymerase, and deoxynucleoside triphosphates were from New En-
gland Biolabs, and spermidine trihydrochloride used in the digestion of genomic
DNA was from Sigma.
Nylon membranes (Hybond N) and 32P-labeled nucleotides were from Am-
ersham, hybridization solution, QuickHyb, was from Stratagene, and Dulbecco’s
modified Eagle’s medium with high glucose and fetal calf serum were used for
culturing mouse embryo fibroblasts and embryonic stem (ES) cells from Gibco-
BRL and HyClone, respectively. Penicillin-streptomycin, L-Glutamine, minimal
essential medium, nonessential amino acids, trypsin-EDTA, geneticin, and leu-
kemia inhibitory factor or ESGRO were from Gibco-BRL. Gelatin and dimethyl
sulfoxide were from Sigma, and ganciclovir was from Cytovene Syntex. C-20
polyclonal anti-BRCA1 antibody was from Santa Cruz, and monoclonal anti-p53
antibody was from Oncogene. All other reagents were commercial products of
the highest grade available.
C57BL/6 mice used for generating a Trsp conditional knockout carrying Neo-
Trsp flanked by loxP sites were from the stock of one of us (L. Tessarollo),
transgenic FVB/N mice carrying EIIa Cre were obtained from Heiner Westphal
(National Institutes of Health), and transgenic C57BL/6  129 mice carrying the
Cre recombinase driven by the MMTV long terminal repeat promoter or the
WAP promoter were generated previously (42). The care of animals was in
accordance with the National Institutes of Health institutional guidelines under
the expert direction of Grace Lidl and D. L. Sly (National Cancer Institute,
National Institutes of Health, Bethesda, Md.) and Mark St. Clair (National
Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of
Health, Bethesda, Md.).
Construction of targeting vector and generation of cells and mice carrying
target alleles. The methods for preparing the targeting vector and cells and mice
encoding the target alleles are described below in Materials and Methods, while
the identification of each of these components is given in the Results. The
primers used in identifying the various regions inserted during vector construc-
tion and in generating the different regions cloned into the targeted vector are
shown in Fig. 1B and Table 1, footnote a.
Targeting vector construction and generation of Trspfl-Neofl cells. The target-
ing vector was constructed with Neo and Trsp flanked by loxP sites (designated
Trspfl-Neofl) and the regions upstream and downstream of the tRNA gene as
shown in Fig. 1. The targeting vector was linearized with NotI, and ES cells were
electroporated with 20 l of DNA (1 g/l) with a Bio-Rad Gene Pulser set at
250 V with a capacitance of 500 F in a 0.4-cm electrode gap electroporation
cuvette (Bio-Rad). The electroporated cells were transferred to plates containing
ES cell medium and incubated for 18 to 24 h, and the transfected cell population
was positively and negatively selected for 8 to 9 days with 250 g of G418 per ml
and 2 M ganciclovir, respectively.
Candidate ES cell clones were screened for homologous recombination by
Southern hybridization of PvuII-digested genomic DNA, and the resulting cells
carrying a Trspfl-Neofl allele were used to generate chimeric mice.
Generation of Trspfl-Neofl mice. Homologous recombinant ES cell clones car-
rying a Trspfl-Neofl allele were injected into C57BL/6 blastocysts and transferred
to pseudopregnant females. The resulting high-percentage chimeras (90% or
greater based on coat color) were mated to wild-type C57BL/6 mice, and tail
DNA samples from the F1 offspring were analyzed for germ line transmission.
Removal of Neo and Trsp. Mice carrying a Trspfl allele lacking Neo were
generated from recombinant ES cells carrying the Trspfl-Neofl allele (see Fig. 1)
by transfection with a vector carrying the Cre recombinase gene under the
control of the -actin promoter (23). Clones were obtained by G418 selection,
and those cells carrying a Trspfl allele without Neo were identified by Southern
hybridization of PvuII-digested genomic DNA. An ES cell clone that had lost
Neo but retained Trspfl was injected into C57BL/6 blastocysts and transferred to
pseudopregnant females. Resulting chimeras were mated with wild-type
C57BL/6 mice, and tail DNA from F1 offspring were analyzed for germ line
transmission by Southern hybridization and PCR.
Mice carrying Trspfl/fl were mated with transgenic mice carrying EIIa Cre to
obtain a standard knockout of Trsp. Tail DNA of the F1 offspring was analyzed
for the loss of the tRNA gene by PCR as given in the Results.
Conditional removal of Trsp. The MMTV-Cre transgene was identified by
PCR analysis of tail DNA with primers corresponding to the MMTV long
terminal repeat (5-GGT TCT GAT CTG AGC TCT GAG TG-3) and to the
Cre gene (5-CAT CAC TCG TTG CAT CGA CCG G-3), resulting in a 280-bp
PCR product. The WAP-Cre transgene was identified by PCR analysis of tail
DNA with primers corresponding to the WAP promoter (5-TAG AGC TGT
GCC AGC CTC TTC C-3) and to the Cre primer described above, resulting in
a PCR product 240 bp in size. Trspfl/-WAP-Cre or Trspfl/-MMTV-Cre trans-
genic mice were generated by mating WAP-Cre and MMTV-Cre transgenic mice
with Trspfl/fl mice. The presence of Trspfl in Cre transgenic mice was detected.
The offspring were mated with Trspfl/fl mice, and the resulting Trspfl/fl-WAP-Cre,
Trspfl/fl-MMTV-Cre, and Trspfl/fl pups were used for Sec tRNA[Ser]Sec and sel-
enoprotein analysis.
Isolation and aminoacylation of tRNA, RPC-5 chromatography, and Northern
hybridization. Total tRNA was isolated from tissues and aminoacylated with
[3H]serine under limiting tRNA conditions (24), and the resulting labeled seryl-
tRNA was chromatographed twice on an RPC-5 column (27), first in buffer
without Mg2 and then in buffer with Mg2 (14, 25, 36, 37). Seryl-tRNASer is
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more hydrophobic than seryl-tRNA[Ser]Sec in the absence of Mg2, and therefore
elutes later on the RPC-5 column, and is less hydrophobic in the presence of
Mg2, and therefore elutes earlier. The tRNASer and tRNA[Ser]Sec populations
can therefore be chromatographically resolved from each other and quantitated
following labeling with [3H]serine and chromatography as described previously
(14, 25, 36, 37).
The level of the Sec tRNA[Ser]Sec population was also determined by Northern
blot analysis by standardizing the signal obtained with a 32P-5-end-labeled oli-
gonucleotide that was complementary to the 20 nucleotides at the 3 end of
tRNA[Ser]Sec (not including the CCA terminus) against that obtained with a
32P-5-end-labeled oligonucleotide that was complementary to the 20 nucleotides
at the 3 end of serine tRNASer1 (not including the CCA terminus), which was
used as an internal control. This technique was a modification of that of Bosl et
al. (5), where 0.01 A260 unit of total tRNA was electrophoresed on a 15% TBE
(Tris-borate-EDTA)–urea–polyacrylamide gel for 2 h at 180 v, the tRNA was
transblotted onto a nylon membrane for 1.5 h at 30 V, and the membrane was
cross-linked as for Southern blot analysis (37). The membrane was then hybrid-
ized with the tRNA[Ser]Sec probe and washed, the signal level was determined,
and the membrane was stripped of this probe and rehybridized with the serine
tRNASer1 probe. 5-End labeling of probes was carried out with [-32P]ATP in
the presence of T4 polynucleotide kinase following the vendor’s procedures (Life
Technologies), and hybridization assays, washing of filters, and autoradiograms
were carried out as for Southern blot analysis (37).
Labeling of selenoproteins and GPx1 and TR1 assays. Lactating mice with the
genotypes Trspfl/fl-WAP-Cre, Trspfl/fl-MMTV-Cre, and Trspfl/fl were injected in-
traperitoneally with 50 Ci of 75Se/g and sacrificed 48 h after injection. Tissues
and organs were excised and immediately placed into liquid nitrogen and stored
at 80°C until ready for use. Tissues were homogenized in 40 mM Tris-HCl
(pH 7.4)–1 mM EDTA–0.5 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, son-
icated for 2 min, and centrifuged at 4°C for 20 min. Supernatants were electro-
FIG. 1. Targeting vector, targeted allele, and screening strategy used in generating the conditional knockout of Trsp. (A) Map showing the
wild-type allele (upper portion of panel A) encoding Trsp and the restriction sites used in generating the targeting vector (center portion of panel
A) that encodes Neo (with its PvuII restriction site, which is critical in distinguishing between the wild-type and target alleles [see below and text]),
and Trsp flanked by loxP sites (designated by ‹), herpes simplex virus thymidine kinase (HSV-tk), and the NotI restriction sites used in constructing
this vector, and the targeted allele (lower portion of panel A) encoding Trsp and Neo flanked by loxP sites (designated by ‹) and the restriction
sites used in constructing this allele, in identifying homologous recombination and in distinguishing wild-type and targeted alleles (see text) are
presented. Sizes of fragments generated from the wild-type allele (see top of panel A) and targeted allele (see bottom of panel A) by PvuII
digestion are also shown. (B) Primers used in identifying the insertion or generation of different regions during construction of the targeting vector
and in determining the presence of different regions involved in generating the targeted allele and floxed Trsp and/or Neo are shown along with
the sizes of each region cloned into the targeting vector. Maps in panels A and B are not drawn to scale.
TABLE 1. Summary of PCR screening techniques used for recombinationa
Forward primer Reverse primer Expected product Product length Sequencing primer Identification
CKNO5FPROA RCKLMJ 5 flank and 1st loxP 1.7 kb CKNOF11 Recombinant only
CKNO2 RCKLMJ 1st loxP 100 bp CKNO2 Recombinant only
CKNOFNeo CKNO8RP 2nd loxP, gene and 3rd loxP 800 bp CKNO4 & CKNO8RP Recombinant only
Spe1 CKNO8RP Gene only and gene and 3rd loxP 700 bp and 800 bp Wild type & recombinant
(two products)
Spe1 Spe2 Gene and 3rd loxP 700 bp Spe1 Recombinant only
CKNO3A CKNOR12 2nd loxP 700 bp CKNOR12 Recombinant only
a Primer designations and sequences are as follows: CKNO2, GCA ACG GCA GGT GTC GCT CTG CG; CKNO3A, GAC GGC GAT GAT CTC GTC GTG;
CKNO4, GCG ACC AGC GCG CAG TTA ACC; CKNO8RP, CGT GCT CTC TCC ACT GGC TCA; CKNOF11, CCA TCA CCT AGG GAC TCA G; CKNOR12,
AGT GCC TGT CTC CCT AAC T; CKNOFNEO, CGC CGC TCC CGA TTC GCA GCG; RCKLMJ, GGC TGG ACG TAA ACT CCT C; Spe1, CTA GAC TAG
TGG CCG CGT GAG AAG TTT TTC; Spe2, GGC CAG TAC TAG TGA ACC TCT TC.
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phoresed on sodium dodecyl sulfate (SDS)-polyacrylamide gels, separated pro-
teins were transferred to polyvinylidene difluoride nylon membranes, and
transblots were exposed to a PhosphorImager as described previously (21, 37).
Gels were stained with Coomassie blue.
GPx1 activity was assayed directly in extracts, while TR1 activity was assayed
after enrichment on ADP-Sepharose as described previously (37).
Tissues. The tissues used for tRNA[Ser]Sec and selenoprotein analyses from
Trspfl/fl-WAP-Cre, Trspfl/fl-MMTV-Cre, and Trspfl/fl mice were mammary (entire
mammary gland), skin (ears only), spleen, and kidney. The same tissues and, in
addition, liver tissues from heterozygous standard knockout (Trsp/) mice and
their wild-type siblings were used. Tissues were excised from labeled mice and
used immediately for selenoprotein analysis (see above), while those used for
tRNA analysis were immediately placed into liquid nitrogen and stored at 80°C
until ready for use.
Western blot analysis. Protein samples were prepared from kidney and mam-
mary tissues as described above, and 25 g was electrophoresed on SDS–4 to
12% polyacrylamide gels, transferred to polyvinylidene difluoride membranes,
and immunoblotted with anti-BRCA1, anti-p53, and antiactin antibodies, and
the resulting band intensities were quantitated with NIH Image.
RESULTS
Targeting vector. The targeting vector was constructed from
fragments encoding Trsp and the surrounding DNA that were
isolated from a 129/Sv mouse genomic library and cloned into
pPNT, which provided the backbone for the conditional knock-
out vector (Fig. 1A). A 520-bp HaeIII-HpaI fragment encoding
Trsp was cloned into the SmaI sites of pBS246, which con-
tained two loxP sites. The gene and the second loxP site were
PCR amplified with primers Spe1 and Spe2 (see Table 1)
containing SpeI sites at both ends and then subcloned into the
SpeI site of pBSKS. A 1.46-kb SalI-NotI fragment encoding
the region just upstream of the 520-bp Trsp-containing frag-
ment was blunt ended and cloned into the EcoRI site (also
blunt ended) immediately 5 to the floxed phosphoglycerate
kinase (PGK) I promoter/Neo (Neo) cassette of the pLMJ58
plox/Neo vector. The 4,113-bp pLMJ58 plox/Neo vector en-
codes a 1.6-kb EcoRI-XhoI pGKNeobpA fragment, which was
blunt ended and inserted into the blunt-ended BamHI site of
the plox plasmid pBS246. This fragment, which contains the
5-flanking region of Trsp along with Neofl, was released from
the vector as a 3.3-kb NotI-ScaI fragment and cloned into the
NotI and XbaI sites upstream of Trspfl in pBSKS.
A 5.0-kb HpaI-StuI fragment encoding the region immedi-
ately downstream of the Trsp-containing fragment was pre-
pared by initially cloning a 5.1-kb, blunt-ended HpaII-StuI
fragment upstream of the PGK-herpes simplex virus thymidine
kinase-bpA cassette (used for negative selection) into the
blunt-ended XhoI and XbaI sites of pPNT, replacing the Neo
gene. The 3-flanking region or the long arm is upstream of the
PGK- herpes simplex virus thymidine kinase-bpA cassette and
was used for negative selection. The 3.8-kb fragment contain-
ing the 5-flanking sequence and the floxed Neo-Trsp fragment
was released from pBSKS with NotI and SmaI and cloned
into the NotI and HpaI sites of the pPNT vector upstream of
the region containing the 3-flanking fragment of Trsp to yield
the targeting vector (bottom map in Fig. 1A).
Gene targeting and homologous recombination. Following
electroporation of the targeting vector into ES cells and selec-
tion of recombinant cells (see Materials and Methods), candi-
date ES cell clones were screened for homologous recombina-
tion by isolating genomic DNA, digesting with PvuII, and
probing the digests by Southern hybridization. A 270-bp PvuII-
SalI fragment located upstream of the Neo-Trsp-containing
520-bp fragment (designated the 5 probe) was used to monitor
insertion of the 5-flanking region. A 250-bp StuI-PstI fragment
located downstream of the Neo-Trsp-containing fragment (des-
ignated the 3 probe) was used to monitor insertion of the
3-flanking region.
PvuII-digested, wild-type genomic DNA yielded a 7.6-kb
signal with both the 5 and 3 probes, while recombinants
yielded a 6.7-kb signal with the 3 probe and a 2.5-kb signal
with the 5 probe, as this endonuclease cuts once inside the
Neo gene (see Fig. 1A). One hundred sixty selected clones
were screened as potential homologous recombinants. Eight
were identified as homologous recombinants by screening with
the 3-end probe (Fig. 2A). Five of these eight were verified as
true homologous recombinants by PCR (Fig. 2B) and sequenc-
ing with the primers shown in Fig. 1B and Table 1 (see also
legend to Fig. 2B) to have three intact loxP sites flanking Trsp
and Neo.
Trspfl-Neofl mice and Sec tRNA[Ser]Sec analysis. Homologous
recombinant ES cell clones were used to generate a chimeric
mouse carrying a Trspfl-Neofl allele in its germ line as described
in Materials and Methods. All F1 offspring of parental chimeric
and C57BL/6 mice yielded a 9.2-kb signal which represented
the wild-type allele and either the wild-type 129/Sv 7.6-kb allele
or the recombinant 6.7-kb allele as identified by Southern
hybridization with the 3 probe (data not shown). It should be
noted that C57BL/6 mice encode a polymorphism in the region
FIG. 2. Screening of ES cell clones for recombinant, targeted vector inserted DNA. In A, DNA that was isolated from 160 clones, digested with
PuvII, electrophoresed on agarose gels, transblotted as given in Materials and Methods, and hybridized with the 3-end probe yielded nine potential
positives that were rescreened on the same blot, as shown in lanes 2 to 10. Seven of these clones (from lanes 2 to 8) yielded a 2.5-kb signal with
the 5-end probe (data not shown). In B, PCR analysis of these clones with CKNO5FPROA and RCKLMJ as primers yielded a 1.7-kb fragment
(lanes 2 to 8). Subsequent sequencing of the PCR-generated fragments demonstrated the presence of Neofl-Trspfl (see text). Lane 1 in panels A
and B contains molecular size markers.
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where the PvuII site occurs in ES cells that accounts for the
9.2-kb PvuII fragment in this mouse line. About 50% of the
offspring were identified as heterozygous for Trspfl and Neofl.
Offspring from this parental mouse that carried a Trspfl-Neofl
allele were intercrossed to yield mice homozygous for the tar-
geted allele.
Sec tRNA[Ser]Sec levels and isoform distributions in liver,
kidney, heart, lung, brain, spleen, and muscle were examined in
these homozygous mice to determine whether the presence of
Neo had any effect on the expression of Trsp. No differences
were observed in the level of the Sec tRNA population and the
distributions of the isoforms in these tissues of wild-type mice
and mice carrying the homozygous targeted allele (data not
shown), suggesting that the presence of Neo had no influence
on Sec tRNA[Ser]Sec expression.
Generation of Trspfl mice. Neo was removed from recombi-
nant ES cells carrying the Trspfl-Neofl allele by transfecting
these cells with a vector expressing the Cre recombinase under
the control of the -actin promoter. DNA was isolated from
these recombinant cells and digested with PvuII. A fragment
about 100 bp larger than the corresponding wild-type fragment
due to the presence of vector sequences was observed by
Southern hybridization with the 3 probe (Fig. 3A, lane 5). This
fragment was distinguished from the allele lacking Trsp-Neo by
being 500 bp shorter than the corresponding wild-type frag-
ment (Fig. 3A, see lanes 2 to 4 and 6 to 9). The presence of
Trsp and the flanking loxP sites (i.e., Trspfl) was partially con-
firmed by PCR with primers CKNO2 and Spe2, which yielded
a 700-bp product (Fig. 3B, lane 5). Other primer combinations,
Spe1 and Spe2, CKNO2 and CKNO8RP, and CKNO2 and
CKNOR12 and sequencing of the PCR-generated products
further confirmed the presence of Trspfl.
It should be noted that due to the small size difference
between the wild-type and targeted alleles generated by PvuII
digestion, screening was also carried out by PCR with the
primer combinations CKNO2 and Spe2, Spe1 and Spe2,
CKNO2 and CKNO8RP, and CKNO2 and CKNOR12.
Chimeric mice carrying only Trspfl were generated as de-
scribed in Materials and Methods. Analysis of the DNA, as
described above, from the offspring of one of the chimeric mice
confirmed that about 40% of them carried Trspfl without Neo
in the germ line (data now shown).
Intercrosses between mice carrying the Trspfl allele gener-
ated Trspfl/fl offspring, and these mice were used in matings to
generate selective deletion of Trsp in specific tissues and the
standard Trsp knockout mice (see below).
Conditional knockout of Trsp. To induce a tissue-specific
deletion of Trsp, we generated Trspfl/fl-WAP-Cre or Trspfl/fl-
MMTV-Cre mice and used them for Sec tRNA[Ser]Sec and
selenoprotein expression analyses. Trspfl/fl mice were used as
the control. The presence of Trspfl/fl was detected by PCR
analysis with the CKNO2 and CKNO8RP primers as described
in Table 1, footnote a, and the product was a 1.1-kb fragment.
The deletion of Trsp from genomic DNA in mammary epi-
thelium, skin, spleen, and kidney was determined by PCR
analysis (Fig. 4). Trsp was virtually absent in DNA from mam-
mary tissue of Trspfl/fl-WAP-Cre and Trspfl/fl-MMTV-Cre mice
and only partially lost in DNA from skin and spleen of Trspfl/fl-
MMTV-Cre mice. Interestingly, a longer film exposure of the
gel in Fig. 4 revealed a partial loss of Trsp in DNA from the
control tissue, kidney, of Trspfl/fl-MMTV-Cre mice, indicating
low levels of MMTV promoter activity in the control tissue. As
expected, there was no loss of Trsp from DNA of these tissues
in Trspfl/fl, nontransgenic mice.
Phenotypic changes in Trspfl/fl-WAP-Cre, Trspfl/fl-MMTV-Cre
and Trspfl/fl mice. Primiparous females were able to nurse their
litters, and no differences in pup growth were observed.
Whole-mount and histological analyses of tissues harvested
after lactation was fully established (day 10 of lactation) re-
vealed normal mammary development with expanded lumina
FIG. 3. Screening of Cre-transfected cells. In A, DNA was digested with PvuII, electrophoresed on agarose gels, transblotted as given in
Materials and Methods, and hybridized with the 3 probe. Lanes 2 to 4 and 6 to 9 yielded a 7.6-kb wild-type signal and a 7.1-kb signal, indicating
they have lost both Neo and Trsp. Lane 5 yielded a signal with a slight upward shift of 100 bp, indicating loss of Neo. In B, PCR analysis of the
fragments in lanes 2 to 9 of panel A with CKNO2 and Spe2 as primers showed a 700-bp fragment in lane 5, confirming the loss of Neo and presence
of Trsp only in the DNA of cells shown in lane 5 of panel A. Lane 1 in panel A and lanes 1 and 10 in panel B contain molecular size markers.
FIG. 4. Selective removal of Trsp in various tissues. DNA was iso-
lated from breast, skin, spleen, and kidney, and products were gener-
ated by PCR with the CKNO2 and CKNO8RP primers with DNA
from Trspfl/fl (lanes 1 to 4; designated control), Trspfl/fl-MMTV-Cre
(lanes 5 to 8; designated MMTV-Cre), and Trspfl/fl-WAP-Cre (lanes 9 to
12; designated WAP-Cre) mice. PCR with this DNA encoding floxed
Trsp yielded a 1.1-kb fragment, and without floxed Trsp yielded a
0.45-kb fragment.
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that contained secreted milk and lipid droplets (data not
shown) (42, 43).
Sec tRNA[Ser]Sec analysis in tissues of conditional knockout
mice. tRNA was prepared from various tissues of Trspfl/fl-WAP-
Cre, Trspfl/fl-MMTV-Cre, and Trspfl/fl mice; tRNA from Trspfl/fl
mice was used as a control. The tissues selected for analysis
were those reported previously to be affected by the WAP gene
(mammary tissue [42]) or the MMTV gene (mammary tissue,
spleen, and skin [42]). Kidney was used as the control tissue.
Isolated tRNA from each tissue was aminoacylated with
[3H]serine, which labeled the serine and Sec tRNA popula-
tions. These two aminoacylated tRNA populations were sep-
arated from each other by RPC-5 chromatography, and the
amounts of the two major Sec tRNA[Ser]Sec isoforms relative to
the total seryl-tRNA were determined as described previously
(14, 25, 36, 37).
The Sec tRNA[Ser]Sec isoforms differed from each other by a
single 2-O-methylribosyl moiety in the wobble position of the
anticodon and were designated 5-methylcarboxymethyluri-
dine (mcm5U) and 5-methylcarboxymethyluridine-2-O-meth-
ylribose (mcm5Um). The mcm5U isoform eluted earlier from
the RPC-5 column than the mcm5Um isoform. The levels and
distributions of the Sec tRNA[Ser]Sec isoforms were initially
examined in mammary tissue of Trspfl/fl-WAP-Cre, Trspfl/fl-
MMTV-Cre and Trspfl/fl, mice as shown in Fig. 5A, B, and C,
respectively. The levels of the Sec tRNA[Ser]Sec isoforms
dropped dramatically in mammary tissue harboring the Cre
recombinase, and the MMTV promoter-driven Cre was more
efficient in reducing the tRNA[Ser]Sec population than the WAP
promoter-driven Cre. The amounts of the Sec tRNA[Ser]Sec
population relative to the seryl-tRNA population and the dis-
tributions of the isoforms were determined for each of the
other tissues, skin, spleen, and kidney, in the same manner as
for mammary tissue. The data for each of the four tissues
examined are summarized in Table 2.
As shown in Table 2, the level of Sec tRNA[Ser]Sec was
reduced by 80% in mice harboring Cre recombinase driven
by the MMTV promoter and 70% in mice harboring this
enzyme driven by the WAP promoter. The MMTV promoter-
driven Cre also affected the Sec tRNA[Ser]Sec population in
spleen and skin, but the decrease was less than in mammary
tissue, being 54% and 39%, respectively. The distributions of
mcm5U and mcm5Um were only slightly altered in the pres-
FIG. 5. Relative amounts of Sec tRNA[Ser]Sec in mammary tissue of conditional Trsp knockout mice. Total tRNA was isolated from mammary
tissue of Trspfl/fl, Trspfl/fl-WAP-Cre, and Trspfl/fl-MMTV-Cre mice, the tRNA was aminoacylated with [3H]serine and fractionated by RPC-5
chromatography, and the amount of [3H]seryl-tRNA[Ser]Sec in Trspfl/fl-WAP-Cre and Trspfl/fl-MMTV-Cre mammary tissue was standardized to that
found in control mammary tissue, with the total [3H]seryl-tRNASer serving as an internal control, as described in Materials and Methods.
TABLE 2. Levels and distributions of Sec tRNA[Ser]Sec isoacceptors
in tissues of Trspfl/fl, Trspfl/fl-MMTV-Cre, and Trspfl/fl-WAP-Cre micea
Tissue Genotype
Sec tRNA[Ser]Sec
%
(total)b
Relative
amtc
Distributiond
(%)
Ratio,
mcm5U/
mcm5Umemcm5U mcm5Um
Mammary Trspfl/fl 2.32 1.00 65.3 34.7 1.88
Trspfl/fl-MMTV-Cre 0.42 0.18 59.0 41.0 1.44
Trspfl/fl-WAP-Cre 0.68 0.29 60.7 39.3 1.54
Skin Trspfl/fl 3.34 1.00 41.9 58.1 0.72
Trspfl/fl-MMTV-Cre 2.03 0.61 58.3 41.7 1.40
Trspfl/fl-WAP-Cre 3.17 0.95 49.8 50.2 0.99
Spleen Trspfl/fl 4.00 1.00 52.9 47.1 1.12
Trspfl/fl-MMTV-Cre 1.85 0.46 50.9 49.1 1.04
Trspfl/fl-WAP-Cre 3.84 0.96 53.8 46.2 1.16
Kidney Trspfl/fl 4.20 1.00 36.4 63.6 0.57
Trspfl/fl-MMTV-Cre 4.90 1.17 38.3 61.7 0.62
Trspfl/fl-WAP-Cre 4.62 1.10 32.1 67.9 0.47
a Total tRNA was isolated from tissues of offspring from matings of the
corresponding parents, and the tRNA was fractionated. The amounts of total Sec
tRNA[Ser]Sec and the distributions of mcm5U and mcm5Um were determined as
given in Materials and Methods.
b Percentage of tRNA[Ser]Sec within the seryl-tRNA population.
c Amount of tRNA[Ser]Sec relative to that in the wild type, which was assigned
a value of 1.00.
d Percentage of mcm5U and mcm5Um in the seryl-tRNA population, resolved
by RPC-5 chromatography (see Materials and Methods).
e Amount of mcm5U divided by the amount of mcm5Um.
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ence of WAP-Cre and MMTV-Cre in each tissue compared to
those in the corresponding control with the exception of the
values in skin. Interestingly, the distribution of the two iso-
forms shifted most dramatically in the presence of MMTV-Cre,
while the distribution in the presence of Wap-Cre was inter-
mediate between that of the control and MMTV-Cre. Similar
levels and distributions of the Sec tRNA[Ser]Sec isoforms were
observed in the kidney of Trspfl/fl-WAP-Cre, Trspfl/fl-MMTV-
Cre, and Trspfl/fl mice.
Selenoprotein synthesis in tissues of conditional knockout
mice. The biosynthesis of selenoproteins in each of the four
tissues from Trspfl/fl-WAP-Cre, Trspfl/fl-MMTV-Cre, and Trspfl/fl
mice was assessed by labeling the selenoprotein population
with 75Se. Proteins from mammary, skin, spleen, and kidney
tissues of labeled mice were extracted and examined by gel
electrophoresis. Coomassie blue-stained gels of total proteins
from these tissues were very similar (lower panel of Fig. 6),
suggesting that the presence of Trspfl/fl or Trspfl/fl coupled with
the Cre-driven promoters had little or no effect on protein
synthesis as a whole. However, analysis of the selenoproteins
detected by 75Se labeling in a representative gel showed vari-
ations in protein expression (upper panel of Fig. 6). Major
selenoprotein bands are designated 1, 1a, 2, 3, 4, and 5. As
reported previously, bands 1 and 1a are likely TR1 (21, 37, 39,
40), while bands 2 and 3, which have been purified and iden-
tified (21, 37), are GPx1 and GPx4, respectively. Band 4 is
unknown, and band 5, which has been purified and identified
(19, 21, 37), is Sep15. Bands 2 to 5 appear to be present in
smaller amounts in mammary tissue carrying the Cre-driven
promoters, whereas band 1 is increased in MMTV-Cre mice.
Each 75Se-labeled band shown in Fig. 6 was quantitated on
a PhosphorImager along with those from two other gels of
protein extracts from mice that were independently labeled
with 75Se. The averages of these values relative to the controls
are shown in Fig. 7. The most significant reductions in seleno-
protein levels occurred in GPx1, GPx4, Sep15, and band 4 in
mammary tissue of MMTV-Cre and WAP-Cre mice. The only
other apparent significant variation occurred in the skin of
FIG. 6. Protein and selenoprotein analysis in tissues of mice carrying floxed Trsp and Cre promoter-specific transgenes. Mice were labeled with
75Se; protein was extracted from tissues, electrophoresed, and stained with Coomassie blue, and 75Se-labeled proteins were detected with a
PhosphorImager (see Fig. 5) as given in Materials and Methods. 75Se-labeled proteins from mammary, skin, spleen, and kidney tissues of Trspfl/fl
(control), Trspfl/fl-WAP-Cre (WAP-Cre), and Trspfl/fl-MMTV-Cre (MMTV-Cre) mice are shown in the upper panels, and total protein analysis is
shown in the lower panels.
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MMTV-Cre mice, where TR1 was approximately 2.5 times
higher than in the corresponding control tissue, and this was
confirmed by direct determination of total TR activity (data
not shown).
In contrast, selenoprotein expression was not affected in the
kidney, as assessed both by 75Se labeling (Fig. 6) and by mea-
suring GPx1 activity (Table 3) and TR activity (data not
shown). Thus, MMTV-Cre and WAP-Cre mice provide an an-
imal model in which selenoprotein expression can be manipu-
lated in both a selenoprotein-specific and tissue-specific man-
ner.
As GPx1 has been shown to be highly affected during alter-
ations of the Sec tRNA[Ser]Sec population (37) (Fig. 6 and 7),
we used this selenoprotein as a marker to measure its activity
directly to further verify the 75Se labeling results and the effects
of reducing the Sec tRNA[Ser]Sec levels in Trspfl/fl-WAP-Cre and
Trspfl/fl-MMTV-Cre mice on selenoprotein synthesis (Table 3).
The results of biochemical assay of GPx1 activities were similar
FIG. 7. Quantitation of 75Se-labeled selenoproteins in tissues of mice carrying floxed Trsp and promoter-specific transgenes. 75Se-labeled bands
of selenoproteins numbered 1, 1a (in spleen and kidney only), and 2 to 5, shown in Fig. 6, and the same labeled bands from two additional
experiments from different mice of the same genotype were quantitated with a PhosporImager as given in Materials and Methods. The results are
reported in the figure as mean values 	 standard deviation (n 
 3). Relative amounts of each band, indicated as a bar, from mammary gland, skin,
spleen, and kidney of Trspfl/fl (control), Trspfl/fl-WAP-Cre (WAP-Cre), and Trspfl/fl-MMTV-Cre (MMTV-Cre) mice are shown.
TABLE 3. GPx1 levels in various tissues of Trspfl/fl,
Trspfl/fl-MMTV-Cre, and Trspfl/fl-WAP-Cre mice
Tissue Genotype
Mean GPx1 activitya
(nmol of NADPH
oxidized/min) 	 SD
% of
control
Mammary Trspfl/fl (control) 47.9 	 3.3
Trspfl/fl-MMTV-Cre 14.1 	 6.6 29.4
Trspfl/fl-WAP-Cre 18.0 	 6.8 37.6
Skin (ear) Trspfl/fl 70.5 	 9.1
Trspfl/fl-MMTV-Cre 54.2 	 4.8 76.9
Trspfl/fl-WAP-Cre 79.6 	 15.8 112.9
Spleen Trspfl/fl 50.8 	 10.5
Trspfl/fl-MMTV-Cre 34.0 	 7.2 66.9
Trspfl/fl-WAP-Cre 56.9 	 9.5 112.0
Kidney Trspfl/fl 164.9 	 22.2
Trspfl/fl-MMTV-Cre 158.0 	 18.2 95.8
Trspfl/fl-WAP-Cre 155.3 	 16.8 94.2
a Biochemical assays of GPx1 were carried out in triplicate as given previously
(37).
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to those observed with 75Se labeling with the exception of that
in skin, which showed a slight reduction in activity.
Brca1 and p53 cancer marker genes. As BRCA1 (the mouse
homolog is designated Brca1) and p53 are significant cancer
marker genes (see the introduction), we examined the levels of
the corresponding proteins in mammary tissue of Trspfl/fl-
MMTV-Cre and Trspfl/fl-Wap-Cre mice. Immunoblots with an-
ti-BRCA1 antibodies showed that Brca1 expression was de-
creased significantly only in mammary tissue of MMTV-Cre
mice, as shown in Fig. 8. p53 expression was significantly up-
regulated in MMTV-Cre mice. Quantitation of these blots con-
firmed that Brca1 expression was reduced by 3-fold and p53
expression was enhanced by 4-fold (see the legend to Fig. 8).
Standard Trsp knockout mice and Sec tRNA[Ser]Sec and
selenoprotein analysis. Mice heterozygous for the loss of Trsp
were obtained by crosses between parents carrying Trspfl/fl and
the EIIa Cre transgene as given in Materials and Methods. Tail
DNA of the F1 offspring was analyzed for loss of the tRNA
gene by PCR with the CKNO2 and CKNO8RP primers. The
mutant allele lacking Trsp yielded a 450-bp fragment, and the
wild-type allele yielded a 900-bp fragment.
Multiple matings between mice that were heterozygous for
the loss of Trsp yielded only wild-type or heterozygous off-
spring (total of 37 wild-type and 39 heterozygous were ob-
tained from four litters). Thus, the loss of Trsp in our floxed
mice was embryonic lethal (see also reference 5).
The levels of the Sec tRNA[Ser]Sec population in various
tissues of Trsp/ and Trsp/ sibling mice were examined by
RPC-5 chromatography and Northern blot hybridization (Ta-
ble 4). The distributions of mcm5U and mcm5Um were exam-
ined only in kidney and liver, as shown in experiment A of the
table. The distributions did not appear to vary significantly in
these tissues with reduced Sec tRNA[Ser]Sec population from
Trsp/ mice compared to the corresponding control tissues
from Trsp/ mice. The levels of the Sec tRNA[Ser]Sec popu-
lation were reduced only about 30% in liver, kidney, and
spleen, about 20% in mammary tissue, and not at all in skin of
Trsp/ mice, as determined by Northern blot hybridization
(experiment B, Table 4).
Labeling of Trsp/ and Trsp/ sibling mice with 75Se and
examination of the resulting selenoproteins in liver, kidney,
spleen, mammary tissue, and skin showed no apparent changes
in the selenoprotein population in these animals (data not
shown). These data suggest that Sec tRNA[Ser]Sec levels are not
limiting in selenoprotein biosynthesis (see also Discussion).
DISCUSSION
The present study describes the generation of mice in which
the Sec tRNA[Ser]Sec gene was inactivated in specific tissues.
The targeted allele encodes Trspfl, which can be used widely in
the loxP/Cre system to remove the gene during development
(4) or in a variety of tissues. Since the tRNA product of this
gene governs the expression of an entire class of proteins, the
selenoproteins, the ability to selectively remove Trsp provides
FIG. 8. Western blot analysis of protein fractions from kidney and mammary tissues of floxed Trsp and promoter-specific transgenes. Protein
samples were separated from Trspfl/fl (control), Trspfl/fl-WAP-Cre (WAP-Cre), and Trspfl/fl-MMTV-Cre (MMTV-Cre) mice by SDS-PAGE and
blotted with antibodies against Brca1, p53, and actin (as control), and band intensities were quantitated as described in Materials and Methods.
Representative Western blots are given in the figure from triplicate experiments with tissues from two different sets of animals. Brca1 was reduced
by 67% 	 8%, and p53 was increased by 400% 	 20% (mean values 	 standard deviation).
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us with an important tool with which to perturb selenoprotein
synthesis during development or in a tissue-specific manner.
Trsp was selectively removed from mammary epithelium
with Cre recombinase that was under the control of the MMTV
long terminal repeat or the WAP gene promoter. The two
promoters target mammary epithelial cells at different times in
development, with MMTV expression occurring even prior to
birth, while high levels of the WAP-driven transgene are found
only in the second half of pregnancy and lactation (42, 43). Sec
tRNA[Ser]Sec levels were reduced by 70% in mammary tissue
with WAP-Cre and 80% in that with MMTV-Cre. In turn, the
selenoprotein levels were selectively reduced in mammary tis-
sue; labeling of the selenoprotein population with 75Se sug-
gested that the amounts of GPx1, GPx4, Sep15, and an 18-kDa
selenoprotein were substantially decreased, but TR1 levels
were less affected. This hierarchy with respect to differential
selenoprotein expression is discussed further below.
MMTV has been reported to be expressed in skin and spleen
(42, 43), and indeed, the levels of the Sec tRNA[Ser]Sec popu-
lation were substantially reduced in these tissues of Trspfl/fl-
MMTV-Cre mice. Even though the Sec tRNA[Ser]Sec popula-
tion was reduced less in skin than in spleen in these mice, TR1
activity was increased over twofold only in skin. This increase
in activity was accompanied by a dramatic change in the dis-
tributions of the two isoforms in skin which were virtually
unchanged in the spleen (Table 2). This observation suggests
that the distribution of the two major Sec tRNA[Ser]Sec plays an
important role in the expression of different selenoproteins (8,
37).
In a previous study, the amount of the wild-type Sec
tRNA[Ser]Sec population was unaltered by the introduction of a
Sec tRNA[Ser]Sec mutant that lacked the highly modified iso-
pentenyladenosine base in its anticodon loop (37). The distri-
bution of the two isoforms, however, changed dramatically in
this tissue; mcm5U increased and mcm5Um decreased. The
alteration in isoform distribution was accompanied by a sub-
stantial reduction in GPx1 in the liver, but TR1 was less af-
fected, while TR3 was significantly enhanced. It was not clear
if the alteration in selenoprotein expression was due to mis-
reading by the isopentenyladenosine mutant Sec tRNA[Ser]Sec
or due to a reduction in the amount of the mcm5Um isoform.
During selenium deficiency in mammals, the most dramatic
change in the Sec tRNA[Ser]Sec population involves the distri-
bution of the two Sec isoforms: mcm5U becomes more abun-
dant and mcm5Um less abundant in cells (25) and numerous
tissues (8, 14). The reverse is true in the same cells and tis-
sues when they are selenium sufficient. These observations
support the possibility that GPx1 expression is linked to a Sec
tRNA[Ser]Sec population in which mcm5Um is enriched (8),
while thioredoxin reductase expression is associated with en-
riched mcm5U (37).
A hierarchy in selenoprotein expression exists in mammals,
in which some selenium-containing proteins are preferentially
expressed during selenium deficiency (reviewed in reference
26) or during alterations in the Sec tRNA[Ser]Sec population
(37). The observations in the present study in which a reduc-
tion in the Sec tRNA[Ser]Sec population and/or an alteration in
the distribution of isoforms results in an alteration of seleno-
protein expression (see Table 3 and Fig. 6 and 7) provide
further support that this hierarchy is directly linked to the
status of the tRNA governing selenoprotein synthesis. An es-
sential element involved in the expression of selenoproteins in
mammals is a stem-loop structure in the 3 untranslated region
of their mRNAs designated the SECIS element (30). Interest-
ingly, there are contrasting viewpoints whether the class of
SECIS elements is involved in the hierarchy of selenoprotein
expression (16, 31), but it would seem that the expression of
certain selenoproteins may be directly linked to distributions
and levels of the two Sec tRNA[Ser]Sec isoforms.
The effect of MMTV-Cre- and WAP-Cre-mediated recombi-
nation on Sec tRNA[Ser]Sec and selenoprotein levels was exam-
ined in the entire mammary gland and not specifically in the
target cells, the mammary epithelium. We investigated seleno-
protein levels during lactation, when approximately 90% of the
mammary gland is composed of epithelium. It is therefore
possible that the Sec tRNA[Ser]Sec could be completely re-
moved in the epithelium of this gland and the low levels of Sec
tRNA[Ser]Sec and altered selenoprotein synthesis observed may
be contributed from other cell types in the gland, including fat,
fibroblasts, and myoepithelium. Isolation of pure secretory ep-
ithelium would no doubt result in degradation of tRNA and
proteins while the specific isolation of these cells was taking
place. There were no phenotypic changes observed in the
mammary gland with respect to generating milk or to the
transfer of milk to the suckling pups, suggesting that altered
selenoprotein synthesis does not play a role in these processes.
TABLE 4. Sec tRNA[Ser]Sec levels in Trsp/ and Trsp/ micea
Expt Tissue Genotype ofoffspring
Sec tRNA[Ser]Sec
% of total or of
control
Relative
amt
Distribution (%) Ratio, mcm5U/
mcm5Ummcm5U mcm5Um
A Liver Trsp/ 3.19 1.00 43.1 56.9 0.76
Trsp/ 1.96 0.61 45.9 54.1 0.85
Kidney Trsp/ 4.18 1.00 44.2 55.8 0.79
Trsp/ 2.89 0.69 41.0 59.0 0.69
B Liver Trsp/ 70.1
Kidney Trsp/ 71.4
Spleen Trsp/ 67.8
Mammary Trsp/ 78.9
Skin Trsp/ 102.7
a Sec tRNA[Ser]Sec levels and distributions were determined by RPC-5 chromatography as described in Materials and Methods and in Table 2, footnotes a to e. The
values for Sec tRNA[Ser]Sec levels in experiment B were determined by Northern blot analysis as described in Materials and Methods.
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Apoptosis is a frequent phenomenon in breast cancer. It has
been shown that BRCA1 may interact closely with p53 in
determining whether a cell should undergo apoptosis or re-
versible growth arrest (32, 45). Cells with functional p53 die by
apoptosis, while similar cells lacking p53 function continue to
proliferate (32). Our studies showing a decrease in Brca1 ex-
pression and an increase in p53 expression in MMTV-Cre mice
suggest that the mice might be more susceptible to breast
cancer if p53 expression was inactivated. Brca1, which is the
mouse homolog of BRCA1, is crucial for the growth and de-
velopment of the mouse embryo (6). It has been reported that
Brca1 homozygous deletions (/) are lethal early in embry-
onic development due to the failure of the affected cells to
proliferate (22). Recent studies show that Wap-Cre- or
MMTV-Cre-mediated excision of Brca1 exon 11 in mouse
mammary epithelial cells resulted in increased apoptosis (44),
with a low frequency of mammary tumor formation which
accelerated in the background of p53 null alleles, suggesting
that genetic instability due to disruption of Brca1 may inacti-
vate p53 leading to tumor formation.
The relationship between selenium and p53 has been ob-
served recently (35, 38, and references therein). Expression of
p53 regulates affected selenoprotein expression in a colon can-
cer cell line (20), whereas one of the selenoproteins, TR1, is
thought to regulate p53 activity through the redox state of
thioredoxin (35). Supplementation of cells with selenium or
selenomethionine activates p53 through upregulation of TR1
(38), while TR1 inhibitors repress p53 (35). However, because
of contrasting patterns of expression of TR1 and GPx1 in
various cancer model systems and in response to p53 expres-
sion (20), the precise relationship between p53 and selenium is
not fully understood. The alteration in p53 and Brca1 levels
following introduction of MMTV-Cre transgenes into Trspfl/fl
mice that was observed in the present study would appear to
add another level of regulation in the relationship between
selenoproteins and p53.
We also generated a standard knockout of Trsp. Consistent
with previous findings (5), no homozygous offspring from het-
erozygous Trsp knockout parents was born, indicating that Sec
tRNA[Ser]Sec and selenoprotein expression are essential for
development. We examined Trspfl/ mice in greater detail to
provide a better understanding of the consequences of remov-
ing one gene copy on the Sec tRNA[Ser]Sec population and on
selenoprotein synthesis. Despite a reduction in the Sec
tRNA[Ser]Sec population in liver and kidney, there appeared to
be little or no effect on the distribution of the two major
isoforms in these tissues or on selenoprotein expression. The
Sec tRNA[Ser]Sec population was also reduced in a number of
other tissues without apparent effect on selenoprotein synthe-
sis suggesting that the levels of this tRNA is not limiting in
selenoprotein expression (5, 7, 37).
Selenium has been shown to provide enormous health ben-
efits to mammals, such as decreasing the incidence of cancer
and heart disease and delaying the aging process, as discussed
in the introduction. Most certainly, the conditional knockout of
Trsp will provide an invaluable tool with which to study the role
of selenoproteins as a chemopreventive agent in a number of
these diseases and under various physiological and pathologi-
cal conditions. The National Cancer Institute, based on an
earlier human clinical trial demonstrating a dramatic reduction
in prostate cancer in males supplemented with 200 g of se-
lenium per day (9), recently undertook a new trial of examining
the effects of selenium and/or vitamin E on prostate cancer in
32,000 men (NCI Selenium and Vitamin E Cancer Prevention
Trial [SELECT], http://cancer.gov/select). This study was un-
dertaken without knowledge of the mechanism(s) of how se-
lenium acts at the molecular level or if selenoproteins are
involved in preventing this disease. The selective reduction or
loss of selenoproteins in specific tissues with Cre-mediated
recombination undoubtedly will help elucidate the role of se-
lenium and selenoproteins in cancer prevention.
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